23 related articles for article (PubMed ID: 38599550)
1. Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Idris A; Shrivastava S; Supramaniam A; Ray RM; Shevchenko G; Acharya D; McMillan NAJ; Morris KV
Nucleic Acid Ther; 2024; 34(3):101-108. PubMed ID: 38530082
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Activity of Ag
Erickson M; Boone TJ; Nadworny PL
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932251
[TBL] [Abstract][Full Text] [Related]
3. Comment on Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.
Kulić Ž
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005944
[TBL] [Abstract][Full Text] [Related]
4. A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication.
Tuttolomondo M; Pham STD; Terp MG; Cendán Castillo V; Kalisi N; Vogel S; Langkjær N; Hansen UM; Thisgaard H; Schrøder HD; Palarasah Y; Ditzel HJ
Mol Ther Nucleic Acids; 2024 Sep; 35(3):102227. PubMed ID: 38939051
[TBL] [Abstract][Full Text] [Related]
5. Reply to Kulić, Ž. Comment on "Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.
Subhadra B; Agrawal R; Pal VK; Chenine AL; Mattathil JG; Singh A
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005945
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant.
Zhou H; Møhlenberg M; Thakor JC; Tuli HS; Wang P; Assaraf YG; Dhama K; Jiang S
Clin Microbiol Rev; 2022 Sep; 35(3):e0001422. PubMed ID: 35862736
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
[TBL] [Abstract][Full Text] [Related]
8. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.
Li T; Zhang Y; Fu L; Yu C; Li X; Li Y; Zhang X; Rong Z; Wang Y; Ning H; Liang R; Chen W; Babiuk LA; Chang Z
Gene Ther; 2005 May; 12(9):751-61. PubMed ID: 15772689
[TBL] [Abstract][Full Text] [Related]
9. Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C
Antiviral Res; 2023 Sep; 217():105677. PubMed ID: 37478918
[TBL] [Abstract][Full Text] [Related]
10. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
12. Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses.
Tolksdorf B; Heinze J; Niemeyer D; Röhrs V; Berg J; Drosten C; Kurreck J
Antiviral Res; 2024 Jun; 226():105879. PubMed ID: 38599550
[TBL] [Abstract][Full Text] [Related]
13. RNAi suppressor: The hidden weapon of SARS-CoV.
Karjee S; Mukherjee SK
J Biosci; 2020; 45(1):. PubMed ID: 32713862
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
